Chronic lymphocytic leukemia (CLL) has a relatively high survival rate. But rates can vary widely, depending on the stage and specific cellular and genetic characteristics of the disease.

Chronic lymphocytic leukemia-- or CLL-- is a type of cancer that happens in your blood and bone marrow, the spongy tissue inside your bones. While the exact cause isn't known, doctors do know that ...

Chronic lymphocytic leukemia (CLL) treatment options depend on your diagnosis. In earlier stages, “watchful waiting” may be recommended. More advanced CLL may require a combination of therapies.

Relapsed chronic lymphocytic leukemia (CLL) occurs when the cancer returns after a person has been in remission for at least 6 months. With relapsed CLL, a person may begin to experience symptoms ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the ...

No writing assistance was utilized in the production of this manuscript. The incidence of chronic lymphocytic leukemia (CLL) is dramatically increased in elderly patients although knowledge on how ...

883 Epcoritamab Monotherapy in Patients (Pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from CLL Expansion and Optimization Cohorts of Epcore CLL-1) at the ASH ...